×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PBM – psyence biomedical ltd. - ordinary shares (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PBM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/20
07:19 am
pbm
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date
Neutral
Report
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date
1/14
07:00 pm
pbm
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
Low
Report
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
1/12
08:30 am
pbm
Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity
Medium
Report
Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity
1/5
11:28 am
pbm
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash [Canadian Business Journal (Canada)]
Medium
Report
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash [Canadian Business Journal (Canada)]
1/5
09:15 am
pbm
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash
Medium
Report
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash
12/19
07:49 am
pbm
Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial [Yahoo! Finance]
High
Report
Psyence BioMed Announces Approval for Use of PsyLabs' Psilocybin Product in Phase IIb Clinical Trial [Yahoo! Finance]
12/19
07:28 am
pbm
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial [Canadian Business Journal (Canada)]
High
Report
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial [Canadian Business Journal (Canada)]
12/19
07:00 am
pbm
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
High
Report
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/14
04:30 pm
pbm
Form 6-K PSYENCE BIOMEDICAL LTD. For: Jan 14
High
Report
Form 6-K PSYENCE BIOMEDICAL LTD. For: Jan 14
1/13
06:18 pm
pbm
Form SCHEDULE 13D/A PSYENCE BIOMEDICAL LTD. Filed by: Kaos Capital Ltd
Medium
Report
Form SCHEDULE 13D/A PSYENCE BIOMEDICAL LTD. Filed by: Kaos Capital Ltd
1/13
07:59 am
pbm
Form 6-K PSYENCE BIOMEDICAL LTD. For: Jan 13
Medium
Report
Form 6-K PSYENCE BIOMEDICAL LTD. For: Jan 13
1/13
06:02 am
pbm
Form 6-K/A PSYENCE BIOMEDICAL LTD. For: Jan 12
Medium
Report
Form 6-K/A PSYENCE BIOMEDICAL LTD. For: Jan 12
1/8
04:06 pm
pbm
Form 6-K PSYENCE BIOMEDICAL LTD. For: Jan 08
Low
Report
Form 6-K PSYENCE BIOMEDICAL LTD. For: Jan 08
12/10
06:09 pm
pbm
Form SCHEDULE 13D PSYENCE BIOMEDICAL LTD. Filed by: Kaos Capital Ltd
Medium
Report
Form SCHEDULE 13D PSYENCE BIOMEDICAL LTD. Filed by: Kaos Capital Ltd
11/21
05:18 pm
pbm
Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 21
Low
Report
Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 21
11/20
05:23 pm
pbm
Form 424B3 PSYENCE BIOMEDICAL LTD.
High
Report
Form 424B3 PSYENCE BIOMEDICAL LTD.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: